Capital Financial Holdings (00204) issued an announcement. The company recently signed a war with Shenzhen Zhongluan Healthcare Industry Co., Ltd....
Zhitong Finance App News, Capital Financial Holdings (00204) issued an announcement. The company recently signed a letter of intent for strategic cooperation with Shenzhen Zhongluan Healthcare Industry Co., Ltd.
Zhongluan Healthcare, an outstanding company focused on regenerative medicine and biotechnology, has a development vision of becoming a leader in this field. The business layout covers various sectors such as scientific research and development, regenerative medicine, biotechnology, and health management services. Through the unique research and development of Zhongluan Medical's cutting-edge technology, it is designed to comprehensively solve human health problems and human anti-aging restoration, which is essential for improving human health. Zhongluan Medical pays special attention to technology and services, and provides comprehensive, one-stop health solutions for valued consumers and partners. With an unparalleled spirit of technological innovation and deep industry insight, Zhongluan Medical has successfully introduced and developed many products and services that meet the diverse needs of customers, setting a model of excellence in the industry.
The company believes that the proposed strategic cooperation under this letter of intent is in line with the Group's long-term development goals and business development strategy. This strategic cooperation with Zhongluan Medical can bring potential profit growth points to both parties, and this move is in line with the overall interests of the company and shareholders. The specific terms and conditions of the formal agreement are subject to review and approval by the board of directors after the company has completed due diligence.